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Analysis of breast milk fatty acid
composition using dried milk samples
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Abstract
Background: The effect of breast milk fatty acid (FA) composition, particularly levels of docosahexaenoic acid
(DHA), on infant health outcomes is unclear. Part of the reason for this is difficulties in collecting, storing and
shipping milk samples to the laboratory. Here we report the validation of a dried milk spot (DMS) system to
measure FA composition to help overcome these obstacles.
Milk FA were measured by gas chromatography and reported as percent of total FA; the FA of primary interest in
this study were DHA and industrially produced trans FA (iTFA). Experiments were carried out using pooled milk
samples from US (n = 5) and Malawian women (n = 50). Experiments compared liquid vs. DMS samples (n = 55),
assessed stability of FA composition under different storage conditions (n = 5), and compared the results from two
different labs using the same methods (n = 5).
Results: Both % DHA and % iTFA levels in liquid and DMS samples were strongly correlated (R2 = 0.99 and 0.99,
respectively, P < 0.0001). The % DHA in DMS samples was stable for up to four weeks at room temperature and up
to three years at -80 °C; only slight deviations from the acceptable range of variability (±15 %) occurred in the 4 °C
and -20 °C conditions for % DHA. The % iTFA was stable under all conditions. All % DHA and % iTFA were within
15 % of the referent when analyzed in two laboratories.
Conclusions: Valid FA composition values can be obtained from DMS samples using this robust collection and
transport system which should facilitate studies of the role of milk FA composition in infant development.
Keywords: Breast milk, Docosahexaenoic acid, Assessment of nutritional status, Lactation, Infant and child nutrition,
Maternal nutrition
Background
The effect of breast milk fatty acid (FA) composition on
infant health outcomes is a promising area of research.
Higher docosahexaenoic acid (DHA, C22:6n3) levels in
milk have been linked to improved visual or neurological
outcomes in term infants in several (but not all) studies
[1, 2]. Milk DHA levels vary widely around the world [3]
and are highly correlated to the mother’s intake of
DHA-rich foods [4] or DHA/fish oil supplement use [5].
Similar to DHA, industrial trans FA levels (iTFA; C18:1 t,
C18:2n6t) in milk are highly related to the mother’s intake
of foods containing trans fats, i.e. some processed foods
and meats, because the body does not synthesize them
[6]. Milk iTFAs were found to be inversely related to long-
chain polyunsaturated FA levels, including DHA, in a co-
hort of German women [6]. iTFA has been shown to
block the synthesis of DHA from its precursor, alpha-
linolenic acid [7, 8]. Because DHA and iTFA levels in milk
are largely diet-dependent (unlike most other milk FA),
there is an opportunity for nutritional interventions to
alter milk FA profile and determine the effects on infant
outcomes. Research in this area, particularly in under-
developed regions, has been hampered by difficulties in
collecting, storing and shipping milk samples to the
laboratory for analysis. Dried blood spots on antioxidant-
treated filter paper have proven to greatly reduce logistical
issues and subject burden during collection while pro-
viding a reliable sample for FA analysis [9, 10]. Here we
report on the validation of a dried milk spot (DMS) sys-
tem for determining milk FA composition that can help
overcome some of these same obstacles.* Correspondence: Kristina@omegaquant.com1OmegaQuant Analytics LLC, Sioux Falls, SD, USA
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Methods
Sources of milk samples used in validation experiments
Pooled samples of liquid milk from US lactating women
(n = 5) with a relatively wide range of DHA levels (0.05 to
0.42 % DHA) that had been submitted for routine FA ana-
lysis were de-identified and used for method development.
After the initial analysis, samples were stored at -80 °C until
stability and validity experiments were conducted.
A second set of samples was collected in Malawi,
Africa (n = 50) as part of a randomized trial of a lipid-
based nutritive supplement (which did not include DHA
or iTFA) for pregnant women [11]. The trial was per-
formed according to Good Clinical Practice guidelines
and the ethical standards of the Helsinki Declaration.
The protocol was approved by the College of Medicine
Research and Ethics Committee, University of Malawi
and the Ethics Committee of Pirkanmaa Hospital District,
Finland. This trial was registered at clinicaltrials.gov with
the identifier NCT01239693.
Breast milk samples from Malawi were collected at
participants’ homes by following milk expression in-
structions that were given by female sample and data
collectors. The mothers expressed the milk into
clean plastic cups, which was immediately mixed
thoroughly with a clean plastic spoon. Ten milliliters
of milk was collected from this mixture into a clean
falcon tube (the rest was given back for the child)
and placed on ice for at most one hour. This was
then taken to a satellite laboratory and aliquoted into
five, 2 ml cryovials. These were stored temporarily at
the satellite laboratory at -20 °C for no more than 2
days after which they were taken to a central sample arch-
ive laboratory and placed at -80 °C for long-term storage.
The samples were shipped to the US on dry ice in
accordance with International Air Transport Association
sample shipment instructions.
Preparation of dried milk spots (DMS)
All DMS samples were prepared in the laboratory by
placing two drops (≈ 50 uL) of thawed milk on absorb-
ent paper (Ahlstrom 226, PerkinElmer, Greenville, SC)
pretreated with OxyStop®, a proprietary antioxidant
cocktail which delays oxidation of FA in dried whole
blood [12].
Laboratory methods
A hole punch from the DMS card or 12.5 uL of thawed
liquid milk were combined (1:40 parts) with the methy-
lating mixture [boron trifluoride in methanol (14 %),
toluene and methanol (35/30/35 v/v)], shaken and
heated at 100 °C for 45 min. After cooling, 40 parts of
both hexane and distilled water were added. After briefly
vortexing the samples were spun to separate layers, and
an aliquot of the hexane (upper) layer which contained
the FA methyl esters was taken for analysis by gas chro-
matography (Shimadzu 2010; SP2560, 100-m column) as
described previously [12]. Data are expressed as a per-
cent of total identified FA; a total of 26 FA between
C10:0 – C22:6n-3 were identified. With each batch of
DMS samples analyzed, two controls (one high and one
low in DHA) were run. A 3-point standard curve was
run at the beginning of each batch from which DHA
levels of the unknowns were determined. Pure standards
had been used to confirm the identities of DHA and
iTFA, and additional confirmation has been made using
gas chromatography-mass spectroscopy in our method
development. The CVs for DHA were 6.0 % and iTFA
3.8 %.
Validation of liquid vs. dried milk spot fatty acid profile
Fifty-five samples of milk from Malawian and US
mothers were used to compare the FA composition of
liquid vs. DMS. To make DMS samples, 1iquid milk
samples were thawed and one drop of milk was placed
on the collection cards. Then the DMS samples were
stored at room temperature in the dark for one week
before analysis (to simulate the approximate time from
collection to analysis in the field). The liquid samples
analyzed immediately after thawing.
Stability of fatty acid profile in dried milk spots: varying
time and temperature
The five pooled milk samples from US mothers were
spotted onto pretreated cards. Several DMS cards from
each pool were stored in the dark in reclosable plastic
bags under each of the following conditions: room
temperature (23 °C), refrigeration (4 °C), standard
freezer (-20 °C), and research freezer (-80 °C). At Days 4,
7, 14, 21, and 28, DMS from the first three storage tem-
peratures were analyzed for FA composition; the Day 0
sample was analyzed immediately after spotting and
served as a reference. Additionally, DMS stored at -20 °C
and -80 °C were tested at months 3, 6, 9, and 12, and then
every 6 months for up to 3 years.
Interlab validation
Pooled milk samples from five US mothers were placed
on DMS cards and sent by express mail at ambient
temperature to an affiliated lab in Seoul, South Korea
(OmegaQuant Asia). Identical DMS samples were saved
at OmegaQuant Analytics in Sioux Falls, SD. Sample
analysis was coordinated to be done on the same day
(about 1 week after shipping). Identical methods were
used in both laboratories.
Statistical methods
All statistics and graphs were analyzed and created with
MiniTab (Student version, State College, PA, USA) and
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GraphPad Prism 6 (GraphPad software, San Diego, CA,
USA). The primary FA of interest were DHA (C22:6n-3)
and iTFA (C18:1 t plus C18:2 t). If necessary, the FA
were log-transformed to meet normality requirements.
Spearman correlations, linear regression, and paired
t-tests were used to compare the liquid and DMS sam-
ples. Correlations between liquid and dry milk samples
were calculated across the full range of DHA values,
and for only those samples with DHA < 1.0 %. The
latter is the range in which the vast majority of milk
DHA levels lies worldwide [3]. For the stability and
inter-lab validation studies, an acceptable range of
15 % of the FA baseline or reference value was
determined, as per FDA guidelines [13]. If the FA
value remained within the acceptable range over time
and in different temperature conditions, it was con-
sidered stable. In addition, the entire FA profile was
assessed for validity and stability and presented in the
Additional files.
Results
Validation of liquid vs. DMS FA profile
The % DHA of the liquid and DMS samples were highly
correlated for both the whole set (R = 0.998, P < 0.0001,
Fig. 1a) and a subgroup with less than 1 % DHA (R = 0.991,
P < 0.0001, Fig. 1a). The mean % DHA value was signifi-
cantly different between the liquid and DMS samples
(0.62 ± 0.47 % vs. 0.69 ± 0.52 %, respectively, P < 0.0001).
The linear regression equation to estimate the liquid milk
% DHA using DMS data was: Liquid % DHA = 0.8974
(DMS % DHA) – 0.0015 (R2 = 0.996, P < 0.0001). For
the < 1 % DHA subset, the regression equation was:
Liquid % DHA = 0.9116 (DMS % DHA) – 0.0054
(R2 = 0.981, P < 0.0001).
The % iTFA from the liquid and DMS samples were
also highly correlated (R = 0.997, P < 0.0001, Fig. 1b).
The mean % iTFA value was significantly different be-
tween liquid and DMS samples (0.37 ± 0.53 % vs. 0.40 ±
0.55 %, respectively, P < 0.0001). The regression equation
to estimate liquid % iTFA from DMS was: Liquid %
iTFA = 0.9605 (DMS % iTFA) - 0.0146 (R2 = 0.994, P <
0.0001). There was a greater than 15 % difference be-
tween the liquid and DMS samples for six FA (C16:1n7t,
C18:1 t, C20:0, C22:0, C24:0, C22:5 n-3; see Additional
file 1); however, each of these FA had a mean relative
abundance of < 2.5 % of total FA.
Stability of FA profile in DMS over time at four
temperatures
Compared to day 0, % DHA stayed within the acceptable
range at all time points in the room temperature (23 °C)
condition for up to 4 weeks or in the -80 °C freezer con-
dition for up to 3 years (Fig. 2). The % DHA increased
slightly over the acceptable range at 4 days in both the
refrigeration (4 °C) and -20 °C freezer conditions but
otherwise remained stable within the acceptable range
for four weeks and three years, respectively. In all condi-
tions at all time points % iTFA was stable. Data from all
other FA are presented in Additional files 2, 3, 4 and 5.
Interlab comparison
The % DHA and % iTFA values from five samples an-
alyzed at both OmegaQuant and OmegaQuant–Asia
were within 15 % of the referent (Table 1).
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Fig. 1 Comparison of liquid with dried milk spot for % DHA (a) and %iTFA (b; n= 55). Regression equations for the whole cohort: Liquid % DHA = 0.8974
(DMS % DHA) – 0.0015 (R2 = 0.996, P < 0.0001) and Liquid % iTFA = 0.9605 (DMS % iTFA) - 0.0146 (R2 = 0.994, P < 0.0001). For the subset of samples less
than 1 % DHA, the regression equation was: Liquid % DHA= 0.9116 (DMS % DHA) – 0.0054 (R2 = 0.981, P < 0.0001)
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Discussion
This series of experiments demonstrate that DMS are a
valid sample type to test breast milk FA composition, par-
ticularly % DHA and % iTFA. The % DHA and % iTFA
were highly correlated between the DMS and the liquid
milk samples, the current standard for milk collection. Both
% DHA and % iTFA were stable at room temperature and
-80 °C for up to four weeks and three years, respectively. Fi-
nally, affiliated labs using the same methods analyzed iden-
tical DMS samples and achieved results within 15 % of the
referent. A previous study found that milk FA composition
could be measured using a DMS system, but no compari-
sons with liquid milk or time/temperature stability data
were reported [14]. These data suggest that under field re-
search conditions, DMS can be collected, stored and
shipped to a laboratory without loss of sample integrity.
Among the many bioactive components in milk [15], fats
provide both a source of energy and indispensable building
blocks in the form of essential FA, linoleic acid (n-6) and
alpha-linolenic acid (n-3). Perhaps more importantly, it also
contains the long-chain metabolites arachidonic acid (n-6)
and DHA (n-3), which are highly enriched in brain tissue.
Likewise, there are unhealthful components that can be
carried in milk that can come from diet, such as iTFA [6],
or environmental contaminants such as persistent organic
pollutants [16]. Unfortunately, DHA is particularly low in
the milk of US mothers compared to many other countries
(US average 0.20 % vs. worldwide average 0.32 %) [3, 17],
and even in the relatively small comparison described here,
the five US samples (which were intentionally pooled to
span a “wide” range of DHA levels) had a mean DHA level
of 0.20 % compared to the 0.74 % in the Malawian women.
Similarly, iTFA levels were quite high in women from the
US (1.98 %) compared with Malawi (0.24 %). Absent good
quality dietary intake data in either cohort, one can only as-
sume that DHA intakes are much higher and iTFA intakes
lower in Malawi than in Sioux Falls, SD, US.
Higher DHA levels in milk (and/or corresponding
mother and infant blood levels) have been found to be
beneficial for neurodevelopment and vision in infants
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Fig. 2 % DHA and % iTFA from dried milk spots (n= 5) over time and in different storage conditions. Temperature Storage a, 23 °C [room temperature];
b, 4 °C [refrigeration]; c, -20 °C [standard freezer]; d, -80 °C [research freezer]). Dotted lines represent 15 % deviation from baseline values. Open squares
represent iTFA values; closed circles represent DHA values.
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and young children in some studies, but the evidence is
not conclusive [1, 2, 18]. Data from Tanzanian tribes
with relatively stable lifetime fish intake have found that
the mother avoids excessive depletion of her own DHA
stores while breastfeeding if her erythrocyte DHA level
is ~ 8 % of total FA, which corresponds to a milk DHA
level of ~ 1 % [4]. There is not yet enough clinical evi-
dence to recommend “optimal” DHA milk levels for
healthy term infants. Premature infants, however, appear
to benefit from milk with augmented DHA levels (either
from DHA-enriched milk fortifier or mother’s DHA sup-
plementation) because the infant misses out on signifi-
cant DHA transfer during the third trimester, the period
of greatest brain growth and placental DHA transport in
pregnancy [19, 20]. Moreover, DHA may decrease the risk
of (or help treat) common complications in premature
infants, such as bronchopulmonary dysplasia, necrotizing
enterocolitis and retinopathy of prematurity [20].
A limitation of this validation study was the use of
DMS samples that had been frozen as liquid milk,
thawed then spotted onto the filter paper rather than
spotted fresh. Due to the timing of the initiation of our
collaboration with the research team, it was not possible
to do the analyses on fresh samples. However, FA in
liquid milk samples stored at -80C are stable and simu-
lating the DMS using thawed milk and storing for 1 week
at room temperature still demonstrates the value of
DMS compared to traditional collection and storage
methods.
Difficulties in collecting, storing and transporting milk
samples, particularly in field research, have limited ad-
vancements in this area. The method described here had
the potential to overcome some of these challenges. One
limitation of the DMS method is that (at present), the
concentration of FA in milk (e.g., mg/mL) cannot be
measured, only the percent composition. However, few
researchers in this field would consider this a limitation
since the vast majority of milk FA researchers have used
the percent composition approach. Its appeal lies in the
robustness of the analytical method, the long tradition of
use, and the ability to compare results between studies.
In addition, since milk percent FA composition is
relatively stable during a feed and throughout the day
[21, 22], samples may be collected anytime during the
day which allows for flexibility in study design. These
considerations aside, the primary reason for measuring
milk FA concentrations is to determine the total daily
FA intake of the infant, and the difficulties associated
with this determination are not insignificant. Whereas
measuring concentrations per se is not difficult, it is very
challenging to measure the other variables needed to
calculate the total milk FA intake per day. These include
the marked within-day and within-mother variations in
both milk volume [23] and milk fat content [24], plus
the practical difficulties of precisely determining how
much milk the baby actually consumed on a given day.
Because of these challenges, it has long been the practice
researchers to express milk DHA status as a percent ra-
ther than a concentration, which is doable with DMS
samples.
Conclusion
Logistic challenges in collection, storage and transport
of samples have impeded studies where simply measur-
ing milk FA composition is the goal. The ability to col-
lect samples as DMS instead of liquid milk and to store
and ship at ambient temperature provides a cost-
effective, practical alternative without compromising the
quality of the FA data. In a parallel setting, dried blood
spot samples have been used for the determination of
blood FA composition for many years [9, 10] and has
facilitated FA research [25], particularly in studies of
infants and children [26, 27] and in subjects in remote
locations [12]. The ability to measure folate, retinol and
markers of inborn errors of metabolism (e.g. phenylke-
tonuria) in dried blood spots has revolutionized research
and testing in infants [28]. The ability to utilize DMS to
measure milk FA (and perhaps other analytes) should
facilitate more research on the role of FA nutrition in
human development.
Table 1 Comparison of % DHA and % iTFA values from
identical samples analyzed affiliated labs, OmegaQuant Analytics
(Sioux Falls, South Dakota, US) and OmegaQuant-Asia (Seoul,
South Korea)
% DHA
Samples Referencea Acceptable
rangeb
OmegaQuant OmegaQuant-
Asia
1 0.06 % 0.05–0.07 % 0.06 % 0.07 %
2 0.08 % 0.07–0.09 % 0.07 % 0.09 %
3 0.16 % 0.14–0.18 % 0.15 % 0.16 %
4 0.32 % 0.27–0.37 % 0.30 % 0.34 %
5 0.45 % 0.38–0.52 % 0.41 % 0.49 %
Average 0.21 % 0.18–0.25 % 0.20 % 0.23 %
% iTFA
Samples Referencea Acceptable
rangeb
OmegaQuant OmegaQuant-
Asia
1 2.15 % 1.83–2.48 % 2.22 % 2.09 %
2 2.52 % 2.14–2.89 % 2.65 % 2.38 %
3 2.07 % 1.76–2.38 % 2.23 % 1.92 %
4 1.56 % 1.32–1.79 % 1.69 % 1.42 %
5 1.09 % 0.92–1.25 % 1.10 % 1.08 %
Average 1.88 % 1.60–2.16 % 1.98 % 1.78 %
aThe reference values for % DHA and % TFA are the average of the values
from each lab
bAcceptable range is ± 15 % from the reference value
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The datasets supporting the conclusions of this article
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Additional file 3: Fatty acids (C10:0 – C22:6n-3) from dried milk spots
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from baseline values. Fatty acids that represent < 3 % of total fatty acids are
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total fatty acids are in the left panel; all others are in the right panel.
Fatty acids with values exceeding 15 % of baseline at any time point:
C10:0, C16:1n7t, C20:1n9, C18:3n-3, C20:2n-6, C22:0, C20:3n-6, C20:4n-6,
C24:0, C20:5n-3, C24:1n9, C22:4n-6, C22:5n-6, C22:5n-3, C22:6n-3.
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spots stored in a research-grade freezer (-80C) for 3 years. Error bars
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total fatty acids are in the left panel; all others are in the right panel.
Fatty acids with values exceeding 15 % of baseline at any time point:
C10:0, C16:1n7t, C18:3n-6, C20:1n-9, C18:3n-3, C22:0, C20:3n-6, C20:4n-6,
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